According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

The Rs 3,395 crore Initial Public Offering (IPO) of Anthem Biosciences, the Bangalore-based contract research, development, ...

Among investor categories, Non-Institutional Investors (NIIs) have shown the highest interest, bidding 1.55 times their ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

The initial public offer of Anthem Biosciences received bids for 14,47,66,596 shares as against 4,40,70,682 shares on offer, according to stock exchange data at 17:00 IST on Tuesday (15 July 2025).

The mainline issue will close for public subscription on Wednesday, July 16. The basis of allotment of shares is likely to be ...

Anthem Biosciences IPO sees 20% GMP premium and strong subscriptions on Day 2; check allotment, listing, and key dates now!

With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

Anthem Biosciences' initial share sale received bids for 14,47,66,596 shares, as against 4,40,70,682 shares on offer, ...

Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...